Orgenesis Financials

Orgenesis Stock Summary

Orgenesis competes with Tff Pharmaceuticals, Quoin Pharmaceuticals, Aerovate Therapeutics, Adagene, and Acrivon Therapeutics,. Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.

Orgenesis Key Financial Ratios

There are many critical financial ratios that Orgenesis' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Orgenesis reports annually and quarterly.

Orgenesis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orgenesis's current stock value. Our valuation model uses many indicators to compare Orgenesis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orgenesis competition to find correlations between indicators driving Orgenesis's intrinsic value. More Info.Orgenesis is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orgenesis' earnings, one of the primary drivers of an investment's value.

Orgenesis Market Pulse

Along with financial statement analysis, the daily predictive indicators of Orgenesis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orgenesis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orgenesis based on widely used predictive technical indicators. In general, we focus on analyzing Orgenesis OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orgenesis's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.